Lung volume reduction surgery beyond the NETT selection criteria

Area of Science:

• Pulmonary Medicine
• Thoracic Surgery
• Respiratory Disease Research

Background:

• Lung volume reduction surgery (LVRS) has demonstrated success in clinical trials for advanced emphysema.
• Initial evidence focused on patients with heterogeneous, upper-lobe predominant emphysema and specific lung function criteria.

Purpose of the Study:

• To summarize current indications for LVRS in diverse emphysema patient subtypes.
• To explore the benefits of LVRS beyond the initially defined patient populations.

Main Methods:

• Review of evidence from large randomized trials (e.g., NETT) and smaller single-center trials.
• Analysis of patient selection criteria and outcomes in various emphysema morphologies and comorbidities.

Main Results:

• LVRS effectively reduces hyperinflation, benefiting patients with homogeneous emphysema.
• Patients with impaired diffusion capacity, moderate pulmonary hypertension, prior LVRS, or alpha-1-antitrypsin-deficiency (AATD) may be candidates for LVRS or re-LVRS.

Conclusions:

• LVRS indications can be expanded to include a broader range of emphysema patients.
• The procedure's benefits, particularly in reducing hyperinflation, are applicable to diverse patient profiles.